
Start with the specific contamination location
Record whether fungal problems arise in stock, storage tanks, paper-machine sections or elsewhere, preserving appropriate testing and operating information. LANXESS’s formulated DCOIT product page describes use against persistent fungal contamination in paper mills, but this does not automatically justify recommending that treatment for every mill problem. First identify the target on site; an unrelated antimicrobial test may not answer the customer’s central questions about quality defects or downtime.
Check whether existing testing covers fungi
If routine monitoring covers only certain bacteria, ask the laboratory whether methods suited to the fungal issue are needed. Different test targets cannot simply be combined into one overall kill rate. Specify sampling location, time and sample handling so a clean circuit’s result does not represent a problematic tank. Retain other possible causes of paper defects whose origins remain uncertain rather than attributing all of them to microbial contamination.
Describe the proposed solution alongside existing procedures
Suppliers need current actives, process additives and treatment locations to assess the specific DCOIT product’s compatibility and use. Separate application evidence for two chemicals does not establish a validated combined program. Professionals should design target-specific trials retaining actual formulations and conditions. This webpage provides no cross-product mixing instructions or promise that adding one component eliminates every recurrence.
Observe process quality and biological control in parallel
Beyond target tests, assess site-defined effects on stock or paper quality, equipment operation and maintenance. If extensive cleaning occurred during the trial, record its contribution separately from chemical assessment. A short period without observed fungi does not establish stability during storage or continuous operation. Follow-up observation should match the customer’s actual production cycle.
Include clear questions in the technical inquiry
Provide contamination locations, existing fungal evidence, current procedures and the main process impacts, requesting product-specific validation information from the supplier. The website presents DCOIT as a verifiable technical option, not an unconditionally strongest supplement. Final reviews should state covered targets, use limits and matters still requiring site confirmation, enabling customers to decide whether trials are warranted without being pushed toward purchase by generic broad-spectrum claims.
Record separately whether recurrence follows shutdown or occurs during continuous production. These timing patterns can help field personnel focus further investigation, but do not directly establish that a microorganism has developed resistance. Suppliers should address specific facts and test results, rather than substituting a new active ingredient for an investigation into contamination sources and maintenance conditions.
Explore further
Do normal bacterial results rule out fungal problems?
No. Check which substances the test method covers.
Can DCOIT be added directly to any paper-mill biocide program?
No. Check formulated-product uses, compatibility and target operating conditions.
References
This article draws on publicly available technical information. Third-party sources do not establish ENVO product approvals, field testing or project experience. Confirm each use against actual supply documents and site conditions.
